1. Home
  2. CSCI vs AMIX Comparison

CSCI vs AMIX Comparison

Compare CSCI & AMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSCI
  • AMIX
  • Stock Information
  • Founded
  • CSCI 1990
  • AMIX 2014
  • Country
  • CSCI Canada
  • AMIX United States
  • Employees
  • CSCI N/A
  • AMIX N/A
  • Industry
  • CSCI
  • AMIX
  • Sector
  • CSCI
  • AMIX
  • Exchange
  • CSCI NYSE
  • AMIX NYSE
  • Market Cap
  • CSCI 11.1M
  • AMIX 8.9M
  • IPO Year
  • CSCI 1996
  • AMIX N/A
  • Fundamental
  • Price
  • CSCI $3.31
  • AMIX $9.52
  • Analyst Decision
  • CSCI
  • AMIX
  • Analyst Count
  • CSCI 0
  • AMIX 0
  • Target Price
  • CSCI N/A
  • AMIX N/A
  • AVG Volume (30 Days)
  • CSCI 5.3K
  • AMIX 1.5M
  • Earning Date
  • CSCI 11-12-2024
  • AMIX 11-11-2024
  • Dividend Yield
  • CSCI N/A
  • AMIX N/A
  • EPS Growth
  • CSCI N/A
  • AMIX N/A
  • EPS
  • CSCI N/A
  • AMIX N/A
  • Revenue
  • CSCI $4,834,000.00
  • AMIX N/A
  • Revenue This Year
  • CSCI N/A
  • AMIX N/A
  • Revenue Next Year
  • CSCI N/A
  • AMIX N/A
  • P/E Ratio
  • CSCI N/A
  • AMIX N/A
  • Revenue Growth
  • CSCI N/A
  • AMIX N/A
  • 52 Week Low
  • CSCI $2.81
  • AMIX $7.51
  • 52 Week High
  • CSCI $11.10
  • AMIX $152.00
  • Technical
  • Relative Strength Index (RSI)
  • CSCI N/A
  • AMIX 44.97
  • Support Level
  • CSCI N/A
  • AMIX $10.00
  • Resistance Level
  • CSCI N/A
  • AMIX $15.00
  • Average True Range (ATR)
  • CSCI 0.00
  • AMIX 2.69
  • MACD
  • CSCI 0.00
  • AMIX -0.01
  • Stochastic Oscillator
  • CSCI 0.00
  • AMIX 19.67

About CSCI COSCIENS BIOPHARMA INC

Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology.

About AMIX AUTONOMIX MEDICAL INC

Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.

Share on Social Networks: